Thymosin Alpha-1 has been used to treat medical conditions including Rheumatoid arthritis,Lupus,Lyme disease,Chronic fatigue,Hepatitis,HIV,and immune dysfunction
Poorly controlled diabetes, given the insulin-antagonistic effects of GH elevation
IV (intravenous) therapy allows for immediate absorption of essential nutrients and medications, making it an invaluable tool in the treatment and management of various health conditions
Among the twelve peptides removed from the Category 2 list (effective April 23, 2026): Removal from Category 2 is separate from the FDAs review of which peptides may be compounded under section 503A
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment